• close button
  • ABOUT (current)
  • CONSULTING
    Asset Prioritization Business Development Competitive Intelligence Licensing Services Merger and Acquisitions Partner Identification Competitive Benchmarking
    Portfolio Management R&D Analysis Pipeline Assessment Market Assessment Regulatory Analysis Due Diligence
    Delveinsight
  • CAPABILITIES
    Medical Devices Market Research Subscription Competitive Intelligence Business Consulting
  • REPORT STORE
  • INSIGHTS
    Blog Events Case-Study COVID-19 Infographics Press Release Whitepaper/Newsletter
  • LOGIN
  • CONTACT
Home / Blog / World heart day 29 09 2018

DelveInsight Blog

Search by Categories

  • Insights
    • Newsletter
    • Whitepaper
    • Infographics
    • Facts & Figures
  • Rare Disease
  • Oncology
  • Cell and Gene Therapy
  • Medical Devices
  • Consulting
  • News & Analysis
    • Articles
    • Notizia
    • Snippet
  • Therapeutic Areas
    Cardiology
    Our expertise in the industry
    • Cardiovascular Diseases
    • Cell and Gene Therapy
    • Central Nervous System
    • Dermatology
    • Dental and Oral Health
    • Rare Diseases
    • Endocrinology and Metabolic Disorder
    • Gastroenterology
    • Genetic Disorder
    • Hematological Disorder
    • Infectious Diseases
    • Male Health
    • Non-Malignant Disorders
    • Genito Urinary System and Sex Hormones
    • Oncology
    • Musculoskeletal
    • Opthalmology
    • Neurology
    • Other Diseases
    • Otolaryngology
    • Immunological and Autoimmune Disorders
    • Respiratory Diseases
    • Pediatrics
    • Sleep Disorder
    • Toxicology
    • Womens Health
    • Nutritional Disorders and Weight loss
Trending:  
  • How Robots Are Introducing A New Dimension To Healthcare Service Delivery
  • World Population Day 2018
  • Enough Of Wasting Away From Cancer: Companies Gear Up To Tackle Cachexia
  • World Psoriasis Day
  • A helping hand in treatment of CRC
  • Cystic Fibrosis Drug Market: Emerging drugs that may improve lung infections
WORLD HEART DAY

WORLD HEART DAY | 29-09-2018

Oct 01, 2018  |   Reading Time: < 1 minute

Tags:

  • Cardiovascular disease

  • CVD

  • heart

RELATED ARTICLE

Pharma News for Sarepta and Ionis

Bristol-Myers Squibb’s Opdivo & Yervo...

Aug 02, 2022

Bristol-Myers Squibb’s Opdivo and Yervoy Combo Fails in Phase III Trial Bristol-Myers Squibb has reported that their ...

Pharma News and Updates for GSK, Roche, and Owkin

GSK’s RSV Vaccine Clears Phase III Test in...

Jun 14, 2022

GSK Starts Preparations for Regulatory Filings as RSV Vaccine Clears Phase III Test in Adults GSK plans to initiate p...

Pharma News for CG Oncology, Amgen, Elevar, and GSK

CG Oncology Teams Up With Merck & BMS...

Jun 07, 2022

FDA Gives Green Signal to First Measles Vaccine in Almost 50 Years GSK announced that the company's vaccine for prote...

Sign Up and Stay Informed

Penetrative insights and rich analysis of Pharma, Biotech and MedTech space.
JOIN-UP NOW!
Editor's Pick
Can denovoSkin Be A Lifesaver for Burn Victims?

Burn is a global public health problem, causing more than 180,000 deaths per year acros...

NexoBrid and its Awaiting US Approval

A Burn takes place when the skin comes into contact with a heat source. Burns can occur...

New Clinical Developments in the Pulmonary Arterial Hypertension Treatment Do...

Pulmonary arterial hypertension is a progressive disease of the lung vascular system, p...

Commercial Roadmap for the Launch: What can Biopharmaceuticals do to Increase...

The Pharma and Biotech Healthcare market has been an ever-changing industry in terms of...

Emerging Market for Organ on a Chip

The organ on a chip is a microfluidic culture device that recapitulates the complicated...

VIEW ALL
RECENT ARTICLES
DelveInsight launches Indication Active Pharmaceutical Ingredient (API) Reports
Bristol-Myers Squibb’s Opdivo & Yervoy Combo Trial; Sarepta’s Gene Therapy SRP-9001 for DMD;...
Where Women Healthcare Stands
GSK’s RSV Vaccine Clears Phase III Test in Adults; Roche’s Tecentriq for Adjuvant NSCLC; Owkin Ba...
Potential of Digital therapeutics and increasing CVDs
Gene Therapies Whitepaper
Toll-like Receptors Agonist
Acute Myeloid Leukemia Newsletter
Sign up For Newsletters

Hear from our subject-matter experts and in-house KOL’s on Pharma and Healthcare market trends.

By DelveInsight

logo

DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

Subscribe for latest updates
USEFUL LINKS

Home

About Us

PharmDelve

Careers

Privacy Policy

Blog

Events

Newsletter

Report Store

Competitive Intelligence

Sitemap

Case Study

Press Release

Market Research

Business Consulting

WE ACCEPT :
Delveinsight
Delveinsight
Delveinsight
Delveinsight

USA: +1(919)321-6187
India: +91-11-45689769,
+91-9650213330

Email: info@delveinsight.com

USA: 304 S. Jones Blvd #2432, Las Vegas NV 89107
India: 428, Corporate Park, Sector-21, Dwarka, New Delhi-110077, India


DelveInsight Business Research LLP © 2022 | Terms & Conditions
@csrf
@error('name')
{{ $message }}
@enderror
@error('email')
{{ $message }}
@enderror
@error('company')
{{ $message }}
@enderror
@error('number')
{{ $message }}
@enderror
@error('message')
{{ $message }}
@enderror

Enter Details to Subscribe
LET US SHARE OUR
EXPERIENCE WITH YOU.
THANK YOU FOR
SUBSCRIBING US!
Thank you for showing your interest.
YOU'RE ALREADY
SUBSCRIBED!